St. Louis

2017 Annual Conference

The 2nd annual IHFDA conference will be held in St. Louis, MO, September 18-20, 2017. This conference has been extended to three days by demand of our membership.

As always, you will receive one year membership to the association when you attend our conference.

IHFDA has chosen The Hilton St. Louis at the Ballpark to host this great conference.

Click here for current agenda

Conference Topics

Perspectives of a victim of diversion

Implementing Safe Opioid Prescribing in Kaiser Permanente Northern California

Alternatives to Incarceration-Drug Court Programs

Analysis of a Diversion Case Involving Tampering: The System Investigator’s Role

Anesthesia Processes and the Risk of Diversion

Case study: A Life of Deception, Diversion, and Theft

Labor Relations Considerations in Cases of Suspected Diversion by Healthcare Personnel

Establishing a Drug Diversion Program on a Large Scale-The Experience of Florida Hospital

Tampering and Substitution-Working with the FDA Office of Criminal Investigators

When DEA Comes Knocking-Perspectives of an Outpatient Cancer Center

Examining the Risks of the Itinerant Diverter

Techniques for Conducting an Effective Interview

Crisis Management in the Healthcare Setting

Understanding the Role and Value of the MRO

Conference Speakers (A-Z)

Dr. Sameer V. Awsare

Dr. Sameer V. Awsare

“Implementing Safe Opioid Prescribing in Kaiser Permanente Northern California”

COMPLETE BIO

Keith Berge, MD

Keith Berge, MD

Anesthesia Diversion, Perspectives from the Mayo Clinic”

COMPLETE BIO

 

Marcus Ellis, Jr

Marcus Ellis, Jr

Drug Courts and their Interaction with Diversion Programs”

COMPLETE BIO

Katrina Hansen

Katrina Hansen

“The New Hampshire Experience: Drug Diversion in Healthcare Settings and Examining Public Health Risk”

COMPLETE BIO

Katrina Haper

Katrina Haper

“Opioid Stewardship”

COMPLETE BIO

Katie Hune

Katie Hune

“Perspectives from a DEA Investigation”

BIO COMING SOON

Austin J Kucher

Austin J Kucher

“Developing a Diversion Prevention, Detection and Response Program: Challenges and Lessons Learned”

COMPLETE BIO

Richard Lafrance

Richard Lafrance

“Perspectives from a DEA Investigation”

BIO COMING SOON

Lauren Lollini

Lauren Lollini

“Diversion by Healthcare Personnel: The Victim’s Perspective”

COMPLETE BIO

Dennis Luken

Dennis Luken

A Life of Deception, Diversion, and Theft”

COMPLETE BIO

Brian McClune

Brian McClune

“Tampering and Substitution – Working with the FDA Office of Criminal Investigators”

BIO COMING SOON

SA Joseph McCulley

SA Joseph McCulley

“Tampering and Substitution – Working with the FDA Office of Criminal Investigators”

COMPLETE BIO

Daniel Perlin, MD

Daniel Perlin, MD

“The Journey of a Physician Addict in Sobriety: A Commitment to Physician Well Being and Patient “

COMPLETE BIO

Michelle Sullivan

Michelle Sullivan

“Investigating Potential Diversion, Important Labor Relations
Considerations”

COMPLETE BIO

Kevin Vanover

Kevin Vanover

“Conducting the Successful Interview”

COMPLETE BIO

Amanda Wollitz

Amanda Wollitz

“Developing a Diversion Prevention, Detection and Response Program: Challenges and Lessons Learned”

COMPLETE BIO

Catherine Woodard

Catherine Woodard

“The Role of State Boards of Nursing in Drug Diversion Cases”

COMPLETE BIO

CE Information

Satisfactory completion
Participants must complete an evaluation form to receive a certificate of completion.  Your chosen sessions must be attended in their entirety.  Partial credit of individual sessions is not available. NOTE: If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.

Physicians
Accreditation Statement – This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Amedco and International Health Facility Diversion Association Conference. Amedco is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement – Amedco designates this live activity for a maximum of 16.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Pharmacists
Amedco is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.  Successful completion of this program qualifies for up to 16.25 contact hours. Note: List day, session title and UAN on PN.

Nurses
Amedco is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

This course is co-provided by Amedco and International Health Facility Diversion Association Conference.  Maximum of 16.25 contact hours.